Pancreas cancer is a tough one to treat. Treatment options are very limited, and not many people survive. TPA has good potential for therapy so it's definitely worth pursuing.

We had previously demonstrated that ATRA is an effective synergist with TPA in treating prostate cancer in the laboratory so it was logical to test the combination against pancreatic cancer as well. We found that the TPA/ATRA combination in cell culture worked better than the individual compounds alone.

We were simultaneously stopping the growth of new cancer cells and killing those already existing. This was most dramatic when we used the TPA/ATRA combination on the tumors.

We are excited about offering clinical trials here in Quincy to give patients another option in the treatment of cancer. Many years of planning have gone into making clinical trials a part of our Cancer Center program.

Maria Freidman performed admirably through a diagnosis of breast cancer and its treatment and Michael Ball battled a serious viral infection. As a result of these and other health issues among the company, audiences got to see the entire original cast perform just 31 of the 108 performances played to date since the show's first preview.

The model using the PC3 prostate cancer cells is irrelevant. So the implications of the findings to the treatment of prostate cancer are questionable. It is dangerous to conclude that reduction of omega-6 fatty acid intake and anti-PI3K inhibitors may be worth considering as future therapeutic approaches to battle prostate cancer.